Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitri Simberg

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Immune Network|September 8, 2025
Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical TrialFrancisco G La Rosa, Larry W Moreland, Luigi Nibali, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2026
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral TumorsJoseph T Duffy, Angela Martin-Regalado, Benedikt E Haupt, et al.
ACS Nano|January 10, 2017
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for SolutionsThomas J Anchordoquy, Yechezkel Barenholz, Diana Boraschi, et al.
ACS Nano|May 20, 2024
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future DirectionsThomas Anchordoquy, Natalie Artzi, Irina V Balyasnikova, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Immune Network|September 8, 2025
Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical TrialFrancisco G La Rosa, Larry W Moreland, Luigi Nibali, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2026
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral TumorsJoseph T Duffy, Angela Martin-Regalado, Benedikt E Haupt, et al.
ACS Nano|January 10, 2017
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for SolutionsThomas J Anchordoquy, Yechezkel Barenholz, Diana Boraschi, et al.
ACS Nano|May 20, 2024
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future DirectionsThomas Anchordoquy, Natalie Artzi, Irina V Balyasnikova, et al.
Pageof 10